An international AACE task force has reviewed the evidence on advanced diabetes technology in adults and produced a consensus statement covering continuous glucose monitoring (CGM), automated insulin delivery (AID) systems, other insulin delivery devices, and emerging technologies including continuous ketone monitoring. The method was a literature review with consensus reached through task force meetings, so this is evidence-informed guidance rather than a new dataset.
What it changes is less the science than the defaults. Much of the argument in a busy clinic is not whether CGM works but who gets it, when a pump conversation starts, and what has to be in place before a device helps rather than confuses. A consensus statement gives a service something to point at when those decisions are contested by a payer or a formulary committee.
It also names implementation as part of the guidance rather than an afterthought. A sensor handed over without structured interpretation produces data a patient cannot act on. Where CGM is self-funded, as it usually is in India, the conversation about who benefits most is the one that has to happen first.
- Record why a given patient is or is not on CGM — the reason is what a later review needs
- Check that anyone starting a sensor has a follow-up booked to interpret the first download
- Ask about hypoglycaemia awareness before assuming a pump is the next step
- Note cost and replacement-sensor affordability explicitly for self-funding patients
- Continuous ketone monitoring is emerging, not established — do not build a protocol on it yet
Why it matters
Consensus guidance is what a service is measured against when a technology request is refused.
Don't overread it
This is consensus guidance, not a trial — it summarises existing evidence rather than adding any.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for diabetes & endocrinology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free